Thrilled to see the dedication of our multi-d team Orla McKivitt (Cashman) being recognized for their practice changing and patient centred efforts! Cork University Hospitals is a pioneering centre for the use of #sgrt for #liver #sbrt thanks to this team 🌟

Delighted to be part of the team bringing Prostate SABR to CUH. Fantastic to have extended our SABR service even further, offering cutting-edge treatment to our patients 🙌 Claire Keating Eoin McGrath OCathail.SM Martin Higgins Cork University Hospitals corkbeo.ie/culture/family…

📢 Don’t miss the Green Journal–Lancet Oncology joint plenary at #ESTRO2025! 🗓 Sun May 4 | ⏰ 11:40–12:45 📍 Plenary Hall Top clinical trials in GI & SBRT from 🇬🇧 🇳🇱 🇨🇳 — including PLATO ACT 4, STAR-TREC, PRIME-RT & more. #Radiotherapy #Oncology #GreenJournal

Looking forward to hearing Campbell Roxburgh present our PRIME RT trial results #ESTRO2025...exciting times in rectal radiation ! University of Glasgow

Not my usual area of interest but supporting team Glasgow 🏴󠁧󠁢󠁳󠁣󠁴󠁿 Great to see a packed plenary hall for Campbell Roxburgh presenting results of PRIME RT in rectal ca RadNetCRUKGlasgow OCathail.SM University of Glasgow #estro25

🇬🇧PRIME-RT results ESTRO today: Durvalumab anti-PDL1+SC/LC TNT in #rectalcancer 52% of pts had CR (pCR/cCR) @ 6mth post-EOT in LARC ⬆️CR rate w SCRT-Durv - may reflect divergent immune effects of RT on TME Privileged to be part of incredible ‘Top trials’ session#ESTRO25

The PRIME-RT team comprises fantastic clinical/ CTU teams from across the UK - University of Aberdeen, Oxford The Christie NHS, NHS Ayrshire & Arran and University of Glasgow UofG Cancer Sciences Queen's University Belfast 🎓 We are especially appreciative of the patients who contributed time and energy to be part of the trial.

Next step is translational analysis of serial tumour samples to understand 1. Why tumours respond more or less than others 2. how RT/anti-PDL1 impacts the TME and response evolution. 👀Watch this space Nigel B. Jamieson Joanne Edwards Owen Sansom 🏳️‍🌈 ACRCelerate CRUK Scotland Inst

thegreenjournal.com/article/S0167-… Delighted to see 👆 online, the first of several soon to be reference publications co-ordinated by ESTRO ESMO - Eur. Oncology on RT& Systemic combos. Fantastic to be involved and congrats to all my collaborators

Radiation is leveraged in 50-60% of all cancer cases but only 9% of the folks involved in writing our treatment guidelines come from the specialty. Source: advancesradonc.org/article/S2452-…

Ralph Weichselbaum Shankar Siva Drew Moghanaki nasser altorki Alex Louie MD, PhD Jonathan Spicer MD PhD Brendon Stiles Biniam Kidane Ben Slotman Matthias Guckenberger Gerry Hanna CTSurgSocMedNetwork Jill Feldman LUNGevity Foundation The copy I requested has arrived today.😀 ▶️Pts feared early mortality more than lower long-term survival.

🎧 Important listen: New figures from Irish Cancer Society reveal stark regional disparities in access to cancer treatment, with avoidable deaths as a result. Professor John Armstrong, President of the Irish Society of Radiation Oncology, unpacks the findings and calls for action

Thank you UCAN IRELAND for highlighting this issue. Our patients deserve the best Colm Burke TD Jennifer Carroll MacNeill TD HSE Ireland Pádraig Rice TD Sorca Clarke Ivana Bacik Department of Health RTÉ News

Drew Moghanaki Eric K. Singhi, MD Balazs Halmos H. Jack West, MD, FASCO Pramesh CS Amol Patel Vivek Subbiah, MD Stephen V Liu, MD Enrique Grande Yakup Ergün WabiSabi David Gandara Dr B Sandeep - The Cancer Doctor ONCO BRUNO Katsuaki Maehara 🇯🇵 Bijoy Telivala Dr Rishabh Jain Rohit Malde Yüksel Ürün Umut. Dişel

Applications are invited for the post of Locum Consultant Medical Oncologist at Cork University Hospitals Apply: rezoomo.com/job/85000/?Loc…

This was a key study from 2024 that supports an “SBRT first” approach to non-surgical mgt of HCC, with RFA utilized whenever SBRT might be less safe. The hepatologists I know, who don’t deliver either treatment, concur. Do yours? cc Laura Dawson

#astro25 NRG Oncology Rtog 0924 trial on 2500 patients testing whole pelvic RT. Negative trial -OS no difference -PCSM no difference -DM no difference -BCR was not SS different with only 4% difference at 10 years. -toxicity increased 3 cooperative group trials now negative:

annalsofoncology.org/article/S0923-… As promised, the 2nd instalment of this fantastic ESTRO ESMO - Eur. Oncology co-ordinated work is now available 👆 looking at ICI, VEGF, TKIs and radiation combos. Read and share widely!

We’ve seen this movie before over the past 2 decades. Trying to replace curative (RT) treatment with non-curative drugs. It’s never ended well, at least not yet.

Thrilled to have our first SIMPLIFY patient randomized this week by Micheal O Cathail 🤩 Huge congrats to our wonderful team in Irish Research Radiation Oncology Group Cancer Research @UCC